image
Aptevo Therapeutics Inc. APVO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.211
-12.4 %
$ 3.91 M
Market Cap
-0.02
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% -40.80% -0.83%
Annual Report FY 10-K 2022-12-31 -74.67% 256.22% -33.84%
Annual Report FY 10-K 2021-12-31 185.26% -48.05% 22.16%
Annual Report FY 10-K 2020-12-31 -86.71% 54.39% 32.88%
Annual Report FY 10-K 2019-12-31 40.56% 24.66% 20.72%
Annual Report FY 10-K 2018-12-31 57.37% -769.96% 4.23%
Annual Report FY 10-K 2017-12-31 -59.77% 106.20% 57.50%
Annual Report FY 10-K 2016-12-31 8.43% -89.52% -107.77%
Annual Report FY 10-K 2015-12-31 -26.36% -16.05% -18.66%
Annual Report FY 10-K 2014-12-31 26741.76% 4.17% 3.49%
Annual Report FY 10-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 19.47% 20.55%
Quarterly Report Q2 8-K 2024-06-30 0.00% 25.98% 26.34%
Quarterly Report Q1 8-K 2024-03-31 0.00% -59.89% 9.97%
Quarterly Report Q4 8-K 2023-12-31 128.97% -19.45% 16.92%
Quarterly Report Q3 8-K 2023-09-30 0.00% 17.41% 15.71%
Quarterly Report Q2 8-K 2023-06-30 0.00% -28.38% -8.15%
Quarterly Report Q1 8-K 2023-03-31 0.00% 214.55% -38.23%
Quarterly Report Q4 8-K 2022-12-31 -84.97% 583.93% -90.20%
Quarterly Report Q3 8-K 2022-09-30 0.00% -9.60% -63.87%
Quarterly Report Q2 8-K 2022-06-30 0.00% 453.13% -32.16%
Quarterly Report Q1 8-K 2022-03-31 28.62% -37.28% 18.54%
Quarterly Report Q4 8-K 2021-12-31 54.45% 11.07% 40.75%
Quarterly Report Q3 8-K 2021-09-30 111.62% -3.03% 23.95%
Quarterly Report Q2 8-K 2021-06-30 557.51% -16.60% 21.40%
Quarterly Report Q1 8-K 2021-03-31 0.00% -250.47% 9.63%
Quarterly Report Q4 8-K 2020-12-31 -73.72% 13.71% 11.57%
Quarterly Report Q3 8-K 2020-09-30 -83.76% 1.92% 40.79%
Quarterly Report Q2 8-K 2020-06-30 -93.57% 48.97% 43.55%
Quarterly Report Q1 8-K 2020-03-31 0.00% 124.11% 33.37%
Quarterly Report Q4 8-K 2019-12-31 42.31% 42.14% 43.27%
Quarterly Report Q3 8-K 2019-09-30 54.72% 44.88% 13.01%
Quarterly Report Q2 8-K 2019-06-30 7.82% -1.43% -3.63%
Quarterly Report Q1 8-K 2019-03-31 72.49% 13.25% 15.27%
Quarterly Report Q4 8-K 2018-12-31 125.20% -44.75% 19.20%
Quarterly Report Q3 8-K 2018-09-30 -5.64% -33.17% -17.19%
Quarterly Report Q2 8-K 2018-06-30 -36.58% -17.47% -16.56%
Quarterly Report Q1 8-K 2018-03-31 -45.05% -39.31% -41.53%
Quarterly Report Q4 8-K 2017-12-31 -67.86% 34.70% 43.67%
Quarterly Report Q3 8-K 2017-09-30 -34.38% 152.78% 85.48%
Quarterly Report Q2 8-K 2017-06-30 5.60% 12.84% 16.89%
Quarterly Report Q1 8-K 2017-03-31 -8.16% 15.93% 26.52%
Quarterly Report Q4 8-K 2016-12-31 5.83% 16.49% -61.43%
Quarterly Report Q3 8-K 2016-09-30 43.33% -465.78% -440.29%
Quarterly Report Q2 8-K 2016-06-30 43.77% 27.53% 29.85%
Quarterly Report Q1 8-K 2016-03-31 -30.83% -7.32% -16.93%
Quarterly Report Q4 8-K 2015-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2015-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2015-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2015-03-31 0.00% 0.00% 0.00%